The Role of CD19 in the Targeted Treatment of Relapsed/Refractory DLBCL

home / precision-medicine / the-role-of-cd19-in-the-targeted-treatment-of-relapsed-refractory-dlbcl

Mazyar Shadman, MD, MPH, and Brian T. Hill, MD, PhD, discuss the importance of CD19-targeted therapy as a promising option in the relapsed/refractory DLBCL setting.